These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7671995)

  • 1. Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists.
    Ponzoni A; Monti JM; Jantos H; Altier H; Monti D
    Eur J Pharmacol; 1995 May; 278(2):111-5. PubMed ID: 7671995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of accumbens m-chlorophenylbiguanide microinjections on sleep and waking in intact and 6-hydroxydopamine-treated rats.
    Monti JM; Ponzoni A; Jantos H; Lagos P; Silveira R; Banchero P
    Eur J Pharmacol; 1999 Jan; 364(2-3):89-98. PubMed ID: 9932710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.
    Ponzoni A; Monti JM; Jantos H
    Eur J Pharmacol; 1993 Nov; 249(3):259-64. PubMed ID: 8287912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
    Monti JM; Jantos H
    Eur J Pharmacol; 2006 Dec; 553(1-3):163-70. PubMed ID: 17059817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.
    Liu W; Thielen RJ; McBride WJ
    Pharmacol Biochem Behav; 2006 Jun; 84(2):370-7. PubMed ID: 16828150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
    Monti JM; Jantos H; Catenaccio V; Xavier S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
    Lagos P; Scorza C; Monti JM; Jantos H; Reyes-Parada M; Silveira R; Ponzoni A
    Eur Neuropsychopharmacol; 1998 May; 8(2):113-20. PubMed ID: 9619689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of local microinjection of selective dopamine D1 and D2 receptor agonists and antagonists into the dorsal raphe nucleus on sleep and wakefulness in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2018 Feb; 339():11-18. PubMed ID: 29137945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat.
    Monti JM; Jantos H; Fernández M
    Eur J Pharmacol; 1989 Oct; 169(1):61-6. PubMed ID: 2574689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglossal nerve response to 5-HT3 drugs injected into the XII nucleus and vena cava in the rat.
    Fenik P; Ogawa H; Veasey SC
    Sleep; 2001 Dec; 24(8):871-8. PubMed ID: 11766156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats.
    Mazzola-Pomietto P; Aulakh CS; Murphy DL
    Psychopharmacology (Berl); 1995 Oct; 121(4):488-93. PubMed ID: 8619014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on the discrimination of durations: evidence for the involvement of 5-HT2A but not 5-HT3 receptors.
    Asgari K; Body S; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2005 Feb; 16(1):43-51. PubMed ID: 15706137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of phencyclidine-induced dopamine release in the rat striatum by the blockade of dopamine D2 receptor.
    Yonezawa Y; Kuroki T; Tashiro N; Hondo H; Uchimura H
    Eur J Pharmacol; 1995 Oct; 285(3):305-8. PubMed ID: 8575518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
    Neisewander JL; O'Dell LE; Redmond JC
    Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
    Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
    Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
    Chen JP; van Praag HM; Gardner EL
    Brain Res; 1991 Mar; 543(2):354-7. PubMed ID: 1711914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.